SODIUM CHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for sodium chloride and what is the scope of patent protection?
Sodium chloride
is the generic ingredient in fourteen branded drugs marketed by Blairex, Abbott, B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Hospira, Miles, Otsuka Icu Medcl, Medefil Inc, Fresenius Medcl, Gvs Tm, Laboratorios Grifols, Liebel-flarsheim, Abraxis Pharm, Hikma, Nexus, Spectra Mdcl Devices, Icu Medical Inc, Jubilant Cadista, Nephron, and Taro, and is included in fifty-six NDAs. Additional information is available in the individual branded drug profile pages.There are nineteen drug master file entries for sodium chloride. Twenty-five suppliers are listed for this compound.
Summary for SODIUM CHLORIDE
| US Patents: | 0 |
| Tradenames: | 14 |
| Applicants: | 21 |
| NDAs: | 56 |
| Drug Master File Entries: | 19 |
| Finished Product Suppliers / Packagers: | 25 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 6,280 |
| Drug Prices: | Drug price trends for SODIUM CHLORIDE |
| What excipients (inactive ingredients) are in SODIUM CHLORIDE? | SODIUM CHLORIDE excipients list |
| DailyMed Link: | SODIUM CHLORIDE at DailyMed |
Pharmacology for SODIUM CHLORIDE
| Drug Class | Osmotic Laxative |
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Anatomical Therapeutic Chemical (ATC) Classes for SODIUM CHLORIDE
US Patents and Regulatory Information for SODIUM CHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | sodium chloride | SOLUTION;INJECTION | 016677-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Fresenius Kabi Usa | BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | sodium chloride | SOLUTION;INJECTION | 088911-002 | May 17, 1985 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Medefil Inc | SODIUM CHLORIDE 0.9% | sodium chloride | INJECTABLE;INJECTION | 202832-006 | Jan 6, 2012 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch